Clinical exome sequencing identifies actionable diagnoses in idiopathic liver disease, suggesting integration into routine practice.
WES/CES yielded actionable diagnosis in considerable number (33%) of patients and identified novel candidate variants in unresolved cases, supporting its integration into clinical workflows for rare liver disorders.
No takes yet. Share an insight, caveat, or question.
Kekilli et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: